Post by
ScienceGirl on Mar 08, 2018 8:35am
Discussion point regarding distribution partner
I don't really agree with this statement from today's release: "In order to maximize both marketing and revenue impact, Tetra and its partner have agreed to launch all products at the same time, once the regulatory framework has been established by Health Canada following the legalization of cannabis. This includes cannabinoid-based as well as non-cannabinoid-based products. Both companies are confident that this strategy will solidify the brand awareness of Tetra's partner in this new product line. The timing of the original LOI was for the commencement of revenue in Q1 2018. Tetra and its partner are now revising that date to Q4 2018" I am picturing chaos of information when weed is legalized where our products won't seem like such a big deal. I think the public and investors will be overwhelmed with information that our product won't stand out. And I don't like linking PP0001 to legalization, I think that takes away our distinguishing points as a Pharma company. What are your thoughts?
Comment by
altitudes on Mar 08, 2018 8:53am
wihtout the DIN we will be another drop in bucket with the influx of products and much more stronger marketing by the big players.Not sure what they are thinking of with this one. They key will be how well they market to the medical community from now legalization. Also why wait till rec legalization medical is already good to go. this is confusing
Comment by
ScienceGirl on Mar 08, 2018 12:25pm
Thanks for your input, it makes sense and has put me at ease!
Comment by
Ripsanddips on Mar 08, 2018 12:35pm
Also worth noting that liability insurance will dictate what products get sold and by whom A product with a DIN will stand a far better chance than one without a DIN Pharmacies won't touch anything without a Din